Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
Simard J, Dumont M, Moisan A-M, et al. (including Joly Y), “Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer” 44:2 (2007) Journal of Medical Genetics, 107-121.
Ce contenu a été mis à jour le 23 juillet 2024 à 15 h 20 min.